| scholarly article | Q13442814 |
| P50 | author | Kathy Andrews | Q37373995 |
| P2093 | author name string | James S McCarthy | |
| Alice S Butterworth | |||
| Tina S Skinner-Adams | |||
| Donald L Gardiner | |||
| Katharine R Trenholme | |||
| Christopher L Peatey | |||
| Nina Eickel | |||
| Timothy MacDonald | |||
| P2860 | cites work | Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa | Q21032444 |
| Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria | Q24538763 | ||
| Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study | Q28139876 | ||
| Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture | Q29547549 | ||
| Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes. | Q30336129 | ||
| Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples | Q31440432 | ||
| Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors | Q33883605 | ||
| From malaria control to eradication: The WHO perspective | Q34984935 | ||
| Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro. | Q35636034 | ||
| Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay | Q35757486 | ||
| The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. | Q35872624 | ||
| Tipranavir: a novel nonpeptidic protease inhibitor of HIV. | Q36520592 | ||
| HIV and malaria co-infection: interactions and consequences of chemotherapy. | Q37154523 | ||
| New treatment options for HIV salvage patients: an overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonists | Q37191941 | ||
| Antiretrovirals as antimalarial agents. | Q39469775 | ||
| Antimalarial activity of sera from subjects taking HIV protease inhibitors. | Q41943246 | ||
| Effect of antimalarial drugs on Plasmodium falciparum gametocytes. | Q44148341 | ||
| HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa | Q46538463 | ||
| A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum | Q47888425 | ||
| Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria | Q48025010 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antimalarial | Q521616 |
| P304 | page(s) | 1334-1337 | |
| P577 | publication date | 2009-12-22 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors | |
| P478 | volume | 54 |
| Q35004887 | Antimalarial effects of human immunodeficiency virus protease inhibitors in rhesus macaques |
| Q47169530 | Blocking Plasmodium falciparum Malaria Transmission with Drugs: The Gametocytocidal and Sporontocidal Properties of Current and Prospective Antimalarials |
| Q62488891 | Brief Report: Antimalarial Benefit of HIV Antiretroviral Therapy in Areas of Low to Moderate Malaria Transmission Intensity |
| Q35103178 | Design and Synthesis of Novel Hybrid Molecules against Malaria |
| Q33916111 | Expanding the Antimalarial Drug Arsenal-Now, But How? |
| Q42102873 | HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites |
| Q36882506 | HIV treatments have malaria gametocyte killing and transmission blocking activity |
| Q35689395 | HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study |
| Q35363679 | In vitro activity of antiretroviral drugs against Plasmodium falciparum |
| Q38294631 | Mutual action of anticancer and antiparasitic drugs: are there any shared targets? |
| Q28542863 | Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates |
| Q38059380 | New approaches in antimalarial drug discovery and development: a review |
| Q38129536 | Plasmodium falciparum gametocytes: with a view to a kill. |
| Q46178209 | Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy |
| Q36743880 | Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies |
| Q38245842 | Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination |
| Q89620853 | The Impact of Antiretroviral Therapy on Malaria Parasite Transmission |
| Q36664149 | The effect of antiretrovirals on Plasmodium falciparum liver stages |
| Q28730788 | The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment |
| Q34509609 | Whole-cell in vitro screening for gametocytocidal compounds |
Search more.